ROKIT America, Inc.
Dietary supplements (anti-aging / consumer health) and regenerative medicine platform (AI-guided organ/skin regeneration, 3D bioprinting) · Los Angeles, CA
S-1 FiledRKAM
ROKIT America, Inc. IPO
Monitoring
S-1 Filed
Priced
Trading
Est. valuation
$35M
Exchange
—
Ticker: RKAM
Status
S-1 Filed
Filed
Apr 15, 2026
IPO timeline
Apr 15, 2026
S-1 filed with SEC
Initial registration statement submitted to the Securities and Exchange Commission.
Upcoming
Roadshow & pricing
Company presents to institutional investors. IPO price and share count are finalized.
Upcoming
First-day trading
Shares available on the open market.
Frequently asked questions
When is ROKIT America, Inc. going public?
ROKIT America, Inc. has not yet announced an IPO date or filed a registration statement with the SEC. FireStrike will update this page when official filings or announcements are made.
What is ROKIT America, Inc.'s IPO valuation?
The estimated offering value is $35M. Final valuation will be determined at pricing.
What exchange will ROKIT America, Inc. list on?
No exchange has been officially announced for the ROKIT America, Inc. IPO.
Has ROKIT America, Inc. filed an S-1 with the SEC?
No. As of the most recent data, ROKIT America, Inc. has not filed a Form S-1 or other registration statement with the SEC.
Sources: FireStrike proprietary index · SEC EDGAR